Home・Lista de Ações・Geron Corp

Geron Corp

Abrir

SetorSaúde

1.4 -0.71

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.3599999999999999

Máximo

1.44

Indicadores-chave
By Trading Economics
Rendimento	25M -3.6M
Vendas	3.8M 52M
EPS	-0.005
Margem de lucro	-7.026
Funcionários	258
EBITDA	27M 3.8M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+185.71% upside

Dividendos
By Acuity
Próximos Ganhos	5 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-57M 949M
Abertura anterior	2.11
Fecho anterior	1.4

Sentimento de Notícias

By Acuity

46%

54%

148 / 340 Ranking em Healthcare

Geron Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

29 de jul. de 2026, 19:32 UTC

Macro Event

Geron Corp shares are lower as market volatility rises following the Federal Reserve's interest rate decision amid ongoing economic growth and inflation concerns.

28 de jul. de 2026, 18:51 UTC

Shares of Geron Corp are lower today amid broader market volatility and uncertainty regarding Federal Reserve decisions. The stock declined since Monday's close.

27 de jul. de 2026, 23:16 UTC

Geron Corp shares are lower in after-market trading, despite earlier gains, with no specific company news driving the decline.

24 de jul. de 2026, 19:46 UTC

Geron Corp shares are lower in Friday's session amid broader market volatility and uncertainty from fluctuating oil prices and new U.S. tariffs.

23 de jul. de 2026, 10:11 UTC

Shares of Geron Corp are higher in pre-market hours, trading above their 20-day moving average. No specific company news was identified.

22 de jul. de 2026, 18:51 UTC

Geron Corp shares are lower today amid broader market trends, as crude oil prices surge due to geopolitical tensions.

21 de jul. de 2026, 23:41 UTC

Geron Corp shares are lower in after-market trading, declining to their lowest point since Tuesday's close. No specific news was identified to explain the drop.

20 de jul. de 2026, 23:56 UTC

Geron Corp shares are lower in after-market hours, continuing a decline since Monday's close amid broader market uncertainties and a drop in the leading economic index.

Comparação entre Pares

Variação de preço

Geron Corp Previsão

Preço-alvo

By TipRanks

185.71% parte superior

Previsão para 12 meses

Média 4 USD 185.71%

Máximo 5 USD

Mínimo 3 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Geron Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

Comprar

Manter

Vender

Com base em 4 analistas que deram avaliações de ações para Geron Corp - Dist nos últimos 3 meses.

Sentimento

By Acuity

148 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.